Calmara has recalled a single lot of its 25mg antihistamine allergy tablets because some bottles may contain 50mg tablets due to a packaging error.
What was recalled
The recall covers Calmara Allergy Relief 25mg tablets, 60-count bottles.
Products and models affected
- Allergy Relief 25mg, 60-count
- Lot number CAL-2417
- Expiration 2027-03
The lot number and expiration are printed on the side of the bottle label.
Why it was recalled
Taking a higher dose than intended can cause increased drowsiness and other side effects, which may be dangerous for children or people who drive. No adverse events have been reported.
What you should do
Stop taking the product and do not give it to children. Return it for a refund and consult a pharmacist if you have questions.
Full Refund
Calmara is offering a full refund for the affected lot. Submit the lot number and a photo of the label to receive your refund.
Important dates & details
- Units affected: one lot (~40,000 bottles)
- Sold: 2025
- Price: $9–$12
- Incidents: none reported
Official Source
U.S. Food and Drug Administration (FDA) — View the official recall notice. Verify all details and file any claim directly through the official source.